159 related articles for article (PubMed ID: 7349092)
1. Effects of combined treatment of L1210 leukemia with adriamycin and pustulan.
Fiszer-Maliszewska L; Mordarski M
Arch Immunol Ther Exp (Warsz); 1981; 29(6):703-10. PubMed ID: 7349092
[TBL] [Abstract][Full Text] [Related]
2. Morphological changes in organs of mice induced by the combination of adriamycin and pustulan.
Fiszer-Maliszewska L; Mordarski M; Madej JA; Kotz J
Arch Immunol Ther Exp (Warsz); 1983; 31(3):365-72. PubMed ID: 6651486
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy of mice bearing L1210 leukemia with adriamycin and mycobacteria.
Fiszer L; Mordarski M
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):873-9. PubMed ID: 749836
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
Avery TL; Roberts D
Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
[TBL] [Abstract][Full Text] [Related]
5. Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats.
Bartholeyns J; Koch-Weser J
Cancer Res; 1981 Dec; 41(12 Pt 1):5158-61. PubMed ID: 6796266
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
Valeriote F; Vietti T; Coulter D
J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
[TBL] [Abstract][Full Text] [Related]
7. The use of liposomes as carriers of therapeutic agents.
Mayhew E; Rustum YM
Prog Clin Biol Res; 1985; 172B():301-10. PubMed ID: 3887426
[TBL] [Abstract][Full Text] [Related]
8. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
Ujiie T
Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
[TBL] [Abstract][Full Text] [Related]
9. Effect of vitamin E on toxicity and antitumor activity of adriamycin in mice.
Tanigawa N; Katoh H; Kan N; Mizuno Y; Tanimura H; Satomura K; Hikasa Y
Jpn J Cancer Res; 1986 Dec; 77(12):1249-55. PubMed ID: 3102429
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
Marks TA; Venditti JM
Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
[TBL] [Abstract][Full Text] [Related]
11. Circadian bioperiodic response of mice bearing advanced L1210 leukemia to combination therapy with adriamycin and cyclophosphamide.
Scheving LE; Burns ER; Pauly JE; Halberg F
Cancer Res; 1980 May; 40(5):1511-5. PubMed ID: 7370988
[No Abstract] [Full Text] [Related]
12. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice].
Mosienko VS; Khasanova LT; Sukolinskiĭ VN; Morozkina TS
Eksp Onkol; 1990; 12(3):55-7. PubMed ID: 2344827
[TBL] [Abstract][Full Text] [Related]
13. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
Israel M; Modest EJ; Frei E
Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
[TBL] [Abstract][Full Text] [Related]
15. Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerate.
Vecchi A; Cairo M; Mantovani A; Sironi M; Spreafico F
Cancer Treat Rep; 1978 Jan; 62(1):111-7. PubMed ID: 626989
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
Pratesi G; Casazza AM; Di Marco A
Cancer Treat Rep; 1978 Jan; 62(1):105-10. PubMed ID: 626988
[TBL] [Abstract][Full Text] [Related]
17. Pre- and co-treatment with xanthophyll enhances the anti-leukemic activity of adriamycin.
Lee KH
J Photochem Photobiol B; 2008 Sep; 92(3):175-9. PubMed ID: 18653355
[TBL] [Abstract][Full Text] [Related]
18. Effects of levamisole administration on treatment with 6-mercaptopurine riboside of mice bearing L1210 leukemia cells.
Miura T; Nogiwa E; Kurashige S; Maekawa T
Cancer Res; 1980 Dec; 40(12):4813-6. PubMed ID: 7438114
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin and ricin, a strongly synergistic combination in mouse leukemia.
Fodstad O; Pihl A
Cancer Treat Rep; 1980; 64(12):1375-8. PubMed ID: 7471125
[TBL] [Abstract][Full Text] [Related]
20. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
Moran RE; Straus MJ
Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
